These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6121233)

  • 1. Patterns of hepatocyte injury in man.
    Sherlock S
    Lancet; 1982 Apr; 1(8275):782-6. PubMed ID: 6121233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of variations in the distribution of copper in liver disease.
    Goldfischer S; Popper H; Sternlieb I
    Am J Pathol; 1980 Jun; 99(3):715-30. PubMed ID: 7386600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases.
    Vij M; Safwan M; Shanmugam NP; Rela M
    Ann Diagn Pathol; 2015 Oct; 19(5):277-82. PubMed ID: 26117383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of copper granules in liver biopsy specimens from various liver abnormalities other than Wilson's disease and biliary diseases.
    Miyamura H; Nakanuma Y; Kono N
    Gastroenterol Jpn; 1988 Dec; 23(6):633-8. PubMed ID: 2464523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic neoductules].
    Fischer HP; Meybehm M; Zhou H; Schoch J
    Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pathology of the liver: light microscopic aspects serving diagnosis and interpretation.
    Popper H
    Semin Liver Dis; 1986 Aug; 6(3):175-84. PubMed ID: 3775396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wilson's disease. A histological review of 7 patients and the value of histological copper positivity in relation to other hepatopathies].
    Blasco A; Domínguez P; Colina F; Castellano G
    Med Clin (Barc); 1992 Feb; 98(6):207-11. PubMed ID: 1373211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey).
    Jensen K; Gluud C
    Hepatology; 1994 Oct; 20(4 Pt 1):1061-77. PubMed ID: 7927209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.
    Sakamoto K; Khai NC; Wang Y; Irie R; Takamatsu H; Matsufuji H; Kosai KI
    Int J Mol Med; 2016 Dec; 38(6):1673-1682. PubMed ID: 27779646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periportal hepatic necrosis in Reye's syndrome. One case in a review of eight patients.
    Bentz MS; Cohen C
    Am J Gastroenterol; 1980 Jan; 73(1):49-53. PubMed ID: 7377172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrahepatic cholestasis in chronic liver disease].
    Roda E; Pezzoli A; Fusaroli P; Fabbri C; Jaboli F; Marchetto S; Azzaroli F; Mazzella G
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():48S-52S. PubMed ID: 9004820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
    Ramm GA; Shepherd RW; Hoskins AC; Greco SA; Ney AD; Pereira TN; Bridle KR; Doecke JD; Meikle PJ; Turlin B; Lewindon PJ
    Hepatology; 2009 Feb; 49(2):533-44. PubMed ID: 19115220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited metabolic diseases of the liver.
    Ishak KG
    Clin Liver Dis; 2002 May; 6(2):455-79, viii. PubMed ID: 12122865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased microfilaments in hepatocytes and biliary ductular cells in cholestatic liver diseases.
    Chung KW; Han NI; Choi SW; Ahn BM; Yoon SK; Nam SW; Lee YS; Han JY; Sun HS
    J Korean Med Sci; 2002 Dec; 17(6):795-800. PubMed ID: 12483004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.
    Paumgartner G
    World J Gastroenterol; 2006 Jul; 12(28):4445-51. PubMed ID: 16874853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y; Seki E; Adachi M; Suetsugu A; Ito H; Moriwaki H; Seishima M; Nagaki M
    Hepatology; 2010 Jan; 51(1):237-45. PubMed ID: 19821528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of liver disease in Indian children: a review of 128 biopsied cases.
    Ramakrishna B; Date A; Kirubakaran C; Raghupathy P
    Ann Trop Paediatr; 1993; 13(2):159-63. PubMed ID: 7687112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of the cholestatic factor in the pathogenesis of intrahepatic cholestasis, found in various liver diseases.
    Mizoguchi Y; Sakagami Y; Monna T; Yamamoto S; Morisawa S
    Gastroenterol Jpn; 1982; 17(3):224-9. PubMed ID: 6811366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.